<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04150432</url>
  </required_header>
  <id_info>
    <org_study_id>Exhaled propofol Children</org_study_id>
    <nct_id>NCT04150432</nct_id>
  </id_info>
  <brief_title>Correlation Between Exhaled Propofol Concentration With Plasma Concentration in Children</brief_title>
  <official_title>Propofol in Expiratory Air, a Comparison With Plasma Propofol, BIS Value and Calculated Plasma Concentration During General Anesthesia in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Children due for elective eye surgery in propofol based anesthesia will be kept at steady
      state propofol infusion for maintenance, ventilation via endotracheal tube. Exhaled propofol
      will be measured continously by Edmon (R) (BBraun) monitor and compared with arterial plasma
      samples of propofol, drawn 3-5 times during the procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of the study is to determine the correlation between simultaneous
      concentrations of propofol in plasma and expiratory air in children during general
      anesthesia.

      Key secondary objectives include correlating plasma and exhaled measurements of propofol with
      electroencephalogram (BIS) values and computer estimated propofol concentrations in plasma
      and brain (TCI: target control infusion) Primary endpoint: Exhaled air and plasma
      concentration ratios of propofol during general anesthesia in children.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 30, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Consecutive patients will participate in the study</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Propofol plasma concentration versus simultaneous exhaled concentration</measure>
    <time_frame>5 hours</time_frame>
    <description>repeated blood samples of propofol concentration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Propofol exhaled correlation versus Bispectral Index value (BIS)</measure>
    <time_frame>5 hours</time_frame>
    <description>repeated blood samples of propofol concentration</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Eye Diseases</condition>
  <arm_group>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>propofol general anesthesia, exhaled measurement of propofol</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Edmon</intervention_name>
    <description>New device for exhaled propofol concentration measurements</description>
    <arm_group_label>propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective eye surgey

        Exclusion Criteria:

          -  known propofol hypersensitivity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristin Thagaard, MD</last_name>
    <role>Study Director</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Johan Raeder, PhD, MD</last_name>
    <phone>004792249669</phone>
    <email>johan.rader@medisin.uio.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johan Raeder, MD, PhD</last_name>
      <phone>004792249669</phone>
      <email>johan.rader@medisin.uio.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 30, 2019</study_first_submitted>
  <study_first_submitted_qc>November 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2019</study_first_posted>
  <last_update_submitted>November 1, 2019</last_update_submitted>
  <last_update_submitted_qc>November 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Johan C RÃ¦der</investigator_full_name>
    <investigator_title>Professor, Consultant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eye Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

